Your Apple Watch may tell you when you’ve had too much to drink or when your blood sugar is too high.
In recent SCC filings, UK medical technology company Rockley Photonics listed Apple as its “biggest customer” who could add its non-invasive sensors to devices to measure a range of markers in blood.
The sensors hid with Apple’s device on the wrist and monitored blood pressure, blood sugar and alcohol levels.
The tech giant’s Apple Watch 6 is the first to measure blood oxygen levels. However, if the new technology is incorporated into the upcoming watch, it could be critical to the more than 436 million people living with diabetes worldwide.
Scroll down for video
Apple may soon add a blood glucose meter to an upcoming smartwatch so that diabetics can non-invasively monitor their blood glucose. Sensors on the Apple Watch 6 (picture) can already measure the blood oxygen content
Rockley Photonics’ products non-invasively track various health functions using infrared, including body temperature, blood pressure, and blood glucose, alcohol and oxygen levels.
“We’re addressing the visible range and expanding it into the infrared range to use laser technology to achieve much higher accuracy than LEDs, which opens up a whole range of possibilities,” said Andrew Rickman, CEO of Rockley, told Gazette Byte.
The company shrunk a tabletop spectrometer to the size of a chip so it “can go much further than clocks today,” added Rickman, “much deeper, but not as deep as a blood draw.”
The mini-spectrometer can detect glucose, urea, lactate and other chemical biomarkers in the blood that are indicators of disease.
Rockley Photonics, maker of chipsets that can track blood sugar levels, blood pressure, and other diagnostics, recently announced that tech giant Apple is its key customer
More than 30 million Americans have type 2 diabetes, which requires frequent blood sugar tests throughout the day.
While the condition most commonly develops in people over the age of 45, according to the CDC, more and more children, adolescents, and young adults are developing it.
Tim Cook, Apple’s CEO, personally tested a blood sugar tracker in 2017, CNBC reported, and there were rumors that such a monitor would ship with the Apple 7, which would hit stores in September 2021.
But Rockley won’t ship its chipsets for health monitoring functions until the first half of 2022 at the earliest, the Telegraph reported.
Rockley announced that Apple generated most of its revenue in SEC filings in 2019 and 2020 as it prepared for a public offering with a forecast valuation of around $ 1.2 billion.
In February, the company announced that it had received $ 65 million to accelerate growth and increased its total capital to over $ 390 million.
“There is a tremendous need for technologies that enable effective digital health and wellness based on the associated public health benefits,” said Rickman, the UK’s first internet billionaire.
“We are committed to our Tier 1 customers and are able to expand their product offerings and the innovative data-driven business models that enable these products,” added Rickman.
According to Tom’s Guide, Apple already has a patent for a blood pressure monitor.
The Apple Watch 6 was released last fall and pointed out a number of health features, including a sensor that measures blood oxygen levels in just 15 seconds by measuring the color of blood flowing through the wearer’s body.
Blood oxygen is usually used as a measure of fitness and heart health, and it reflects how well red blood cells are transporting oxygen around the body.
Critics have pointed out that relying on a smartwatch in lieu of actual medical care can burden consumers with unnecessary medical bills and overwhelm already frayed healthcare systems.
A 2020 study published in the Journal of the American Medical Informatics Association found that only about 10 percent of Apple Watch owners who were made aware of abnormal heart rate were diagnosed with an illness.
The clocks can also cause people to ignore legitimate symptoms, such as dizziness or shortness of breath, because they haven’t received an official warning.
The Apple Watch Series 4 heart monitor, released in 2018, allows users to take an electrocardiogram to measure their heart’s electrical activity.
But consumers often fail to understand that the sensors are much less sophisticated than the EKG you get at a doctor’s office, which collects data from a dozen areas of your heart.